Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NKTX
NKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NKTX News
ImmunityBio Shares Triple in Three Weeks, Short-Sellers Face $500 Million Loss
Jan 21 2026
Yahoo Finance
Nkarta (NKTX) Participates in Evercore 8th Annual Healthcare Conference to Showcase NK Cell Therapy Progress
Dec 02 2025
Globenewswire
Nkarta to Attend Investor Conferences in November
Oct 30 2025
Newsfilter
Nkarta to Present Poster at the Upcoming American College of Rheumatology (ACR) Convergence Meeting
Oct 22 2025
Newsfilter
Nkarta Posts Narrower Loss in Q2
Aug 13 2025
NASDAQ.COM
Needham Reiterates Buy on Nkarta, Maintains $10 Price Target
Aug 13 2025
Benzinga
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
Jun 06 2025
Newsfilter
Nkarta CMO David Shook Steps Down, Shawn Rose To Succeed
Jun 06 2025
NASDAQ.COM
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space
May 15 2025
Benzinga
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
May 15 2025
Benzinga
Needham Maintains Buy on Nkarta, Lowers Price Target to $10
May 15 2025
Benzinga
Nkarta to Participate in an April Investor Conference
Apr 01 2025
Yahoo Finance
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?
Mar 27 2025
Benzinga
Notable Friday Option Activity: CAR, PINS, NKTX
Dec 13 2024
NASDAQ.COM
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
Dec 05 2024
Newsfilter
Nkarta to Participate in an Upcoming Investor Conference
Nov 26 2024
Newsfilter
Show More News
